Transforming Business & TechnologyMarch 8, 2024

In a cover story in May, MIT’s Technology Review magazine touts the biotech patent prosecuted by our firm (Heidi Sease Nebel). The author relates five patents that he concludes will “…transform business and technology…”

One of these is United States patent 6,136,320 that we prosecuted on behalf of Prodigene, Inc. The patent relates to edible vaccines and discloses the making of transgenic plants that express viral proteins so that one could become vaccinated by eating the plant.